Patents by Inventor Gary D. Tollefson

Gary D. Tollefson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6159963
    Abstract: The invention provides a method for treating substance abuse comprising administering an effective amount of olanzapine or pharmaceutically acceptable salt thereof to a patient in need thereof.
    Type: Grant
    Filed: November 25, 1997
    Date of Patent: December 12, 2000
    Assignee: Eli Lilly and Company
    Inventors: Charles M Beasley, Kurt Rasmussen, Gary D Tollefson
  • Patent number: 6147072
    Abstract: The invention relates to a method of treating psychosis, acute mania, mild anxiety states or depression in combination with psychotic episodes by administering to a patient a combination of an atypical antipsychotic and a serotonin reuptake inhibitor.
    Type: Grant
    Filed: September 23, 1997
    Date of Patent: November 14, 2000
    Assignee: Eli Lilly and Company
    Inventors: Franklin P. Bymaster, Kenneth W. Perry, Gary D. Tollefson
  • Patent number: 5958921
    Abstract: This invention relates to the use of the antipsychotic drug olanzapine for the treatment of depression, including depressive signs and symptoms and Major Depression.
    Type: Grant
    Filed: June 18, 1998
    Date of Patent: September 28, 1999
    Assignee: Eli Lilly and Company
    Inventor: Gary D Tollefson
  • Patent number: 5658590
    Abstract: Tomoxetine, a norepinephrine uptake inhibitor, is used to treat attention-deficit/hyperactivity disorder.
    Type: Grant
    Filed: January 11, 1995
    Date of Patent: August 19, 1997
    Assignee: Eli Lilly and Company
    Inventors: John H. Heiligenstein, Gary D. Tollefson